The Rising Influence of Rising Affluence

[DewDiligence]

Yes—I had soured on MON to some degree during its hostile pursuit of SYT. Now that the SYT deal has been killed, MON may make a series of small acquisitions in the ag-chemicals area, but MON is evidently not going to substantially dilute its focus on biotechnology or engage in a tax-inversion that would cause shareholders' unrealized gains to become taxable.

Despite its flaws, MON remains one of premiere plays on The Global Demographic Tailwind. I don't see how the increasing demand for food (and especially protein-based food) triggered by the world's growing population and growing affluence can be satisfied without biotech solutions.